Structure Therapeutics Inc
(GPCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 33,316 | 32,015 | 30,994 | 26,145 | 25,987 |
| Operating Income | -33,316 | -32,015 | -30,994 | -26,145 | -25,987 |
| Other Income | 7,335 | 6,008 | 6,179 | 2,688 | 2,825 |
| Pre-tax Income | -25,981 | -26,007 | -24,815 | -23,457 | -23,162 |
| Income Tax | 53 | 29 | -312 | 405 | 118 |
| Net Income Continuous | -26,034 | -26,036 | -24,503 | -23,862 | -23,280 |
| Net Income | $-26,034 | $-26,036 | $-24,503 | $-23,862 | $-23,280 |
| EPS Basic Total Ops | -0.53 | -0.56 | -0.46 | -0.62 | -0.61 |
| EPS Basic Continuous Ops | -0.53 | -0.56 | -0.46 | -0.62 | -0.61 |
| EPS Diluted Total Ops | -0.53 | -0.56 | -0.46 | -0.62 | -0.61 |
| EPS Diluted Continuous Ops | -0.53 | -0.56 | -0.46 | -0.62 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.19 | -0.17 | N/A | N/A |
| EBITDA(a) | $-36,268 | $-35,070 | $-33,246 | $-27,727 | $-27,557 |